Boehringer Ingelheim Pharma GmbH & Co. KG

Clinical trials with interim analyses: standardizing terminology to increase clarity (2025) Asikanius E, Hofner B, Hampson LV, Wassmer G, Jennison C, Mielke T, Kunz CU, Rufibach K Journal article Relative Bioavailability of Zongertinib, an Orally Administered HER2-Selective Tyrosine Kinase Inhibitor, under Fed and Fasted Conditions in Healthy Male Participants: Results from Two Randomized, Open-Label, Crossover Studies (2025) Pereira H, Wölke S, Sadrolhefazi B, Esmaeili H, Wind S, Gan G, Müller F, et al. Journal article Nonclinical and Clinical Assessments of an Optimized Tablet Formulation of the Novel HER2-Selective Tyrosine Kinase Inhibitor Zongertinib: Focus on Relative Bioavailability and Impact of Variation of Gastric pH (2025) Wölke S, Sadrolhefazi B, Esmaeili H, Wind S, Blattner SM, Gan G, Qiang D, et al. Journal article In vitro transporter substrate properties of previously reported biomarkers for renal OAT1/OAT3-mediated drug-drug interactions (2025) Picurová J, Geßner A, Bartels N, Scheuerlein S, Fischer O, Lochschmidt L, Wenisch P, et al. Journal article Pawsitive impact: How pet contact ameliorates adult inflammatory stress responses in individuals raised in an urban environment (2025) Langgartner D, Weimer K, Brunner-Weisser J, Winkler R, Mannes M, Huber-Lang M, Sterrett JD, et al. Journal article Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease. (2025) Herrington WG, Staplin N, Agrawal N, Wanner C, Green JB, Hauske SJ, Emberson JR, et al. Journal article Ophthalmological research in Germany: suggestions by an international expert panel (2024) Ader M, Cursiefen C, Fauser S, Gliem M, Helbig H, Lagrèze W, Marshall J, et al. Journal article The effect of carbamazepine, a strong CYP3A inducer, on the pharmacokinetics of zongertinib in healthy male volunteers (2024) Tian X, Esmaeili H, Minich D, Seitz F, Roessner PM, Wind S, Grempler R, et al. Journal article New Biomarkers for Renal Transporter-Mediated Drug–Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans (2024) Geßner A, König J, Wenisch P, Heinrich M, Stopfer P, Fromm M, Müller F Journal article Ophthalmologische Forschung in Deutschland: Evaluation durch ein internationales Expertengremium (2024) Ader M, Cursiefen C, Fauser S, Gliem M, Helbig H, Lagrèze W, Marshall J, et al. Journal article